SlideShare a Scribd company logo
1 of 12
Download to read offline
Earnings release

3Q08
November 14, 2008
Business segments




    Healthcare Administration Services   Dental HMO
                                                                          Assistance Services
    Ranking: #1                          Ranking: #4
                                                                          Ranking: #1
    Number of lives: 1.38 million        Number of lives: 751 thousand
                                                                          Number of items: 21.3 million
    No underwriting risk. Fee business   Underwriting of frequency risk
    only.                                                                 Underwriting of frequency risk




                                      Shared structure
                     Network management – Contact Center – Claims processing




2
Recent events

      ACQUISITION DENTAL – Today, November 13, 2008, Tempo announces an
    acquisition of 55% stake of Presdental Assistência Odontológica Empresarial S.A.
    (Presdental), a dental plan company offering services to approximately 35 thousand
    beneficiaries. The acquisition of 6% is still subject to ANS approval (Brazilian Health
    Regulatory Agency).

      ACQUISITION HEALTH – On 08/31/2008, Tempo acquired 100% stake of Multicare
    Consultoria e Administração de Recursos em Saúde (“Multicare”), with a total of
    approximately 15 thousand lives. The acquisition of 51% is still subject to ANS
    approval. Multicare provides health services to self-insured companies.

    STOCK BUYBACK PROGRAM - Tempo announced that its Board of Directors approved
    on 11/13/08 a Buyback program of common shares. The maximum number of
    common shares on this Buyback program is of 8,276,702 and will last for 365 days.




3
FINANCIAL AND OPERATING
PERFORMANCE
Tempo - Consolidaded

    Net Revenue - Tempo (R$MM)                EBITDA - Tempo ($RMM)                    Margem EBITDA - Tempo ($RMM)




                                   189,8                                                                                     9,9%
                                                                           18,8
             142,4                                                                                 9,3%
                                                         13,2




           3Q07A             3Q08A
                                                     3T07A      EBITDA
                                                                         3T08A                  3T07A                     3T08A
                     Net Revenue
                                                                                                          Margem EBITDA


                NET REVENUES                                    EBITDA                                      EBITDA Margin
       Net Revenue grew 33.3% in 3Q08               Economies of scale and synergies
         versus the same period of the                 continue to boost margins                M & A Transactions during 08 and
      previous year, reaching a total of R$                                                                synergies
                 189.8 million.




5
Health segment
    Net Revenue (in R$MM)                   General and Administrative Expenses (in R$MM)      Adjusted EBITDA (in R$MM)


                                                                               14.9%
                                                         16.1%                                                               5.4%

                                                                                                          3.6%

                                    112,0
               78,2                                                            16,7
                                                         12,6                                                              6,1

                                                                                                         2,8


            3Q07A             3Q08A                    3Q07A                 3Q08A
                      Net Revenue                        General and Administrative Expenses         3Q07A             3Q08A

                REVENUES                                        SG&A                                          EBITDA
       Revenue growth driven by lives             Health segment accumulated a                      EBITDA powered by growth and
    increase and Home Care acquisition.             total of R$ 16.7 MM in SG&A                                M&A
        Growth for 3Q08 came to R$               expenses during the 3Q08, which
                 33.8MM                           was R$ 4,1 million above 3Q07.
                                                       Despite the increase in
                                               expenses, Health segment growth in
                                                this period generated economies of
                                               scale, improving the business margin




6
Dental segment: 2008 pro forma results
      Net Revenue (in R$MM)                                Cost of Rendered Services (in R$MM)                     EBITDA (in R$MM)

                                                                                                                                               21,8%
                                                                       50.2%
                                                                                            43.1%
                                                                                                                                20,4%




                                    24,0                                                   10,8
                                                                                                                                               5,2


                                                                        2,7
                 5,4
                                                                                                                                1,1

            3Q07A                3Q08A                             3Q07A              3Q08A
                                                                                                                            3Q07A           3Q08A
                   REVENUES                                                 LOSS RATIO                                                 EBITDA
      Strong top line growth powered by                        Significant improvement in loss ratio                     Continues EBITDA margin expansion
        M&A and solid organic growth




All figures in this slide take into consideration the acquisitions made in 2007 and consolidated into the Company's financials starting
January 1st, 2008 even though they were waiting for approval by ANS.
7
Strong combination between organic and M&A
           growth
    Growth Breakdown - Dental Segment                              Growth by Acquisition Organic Growth


                              26%



                 29%                      45%

                                                                                93%




                                                                                                     23%
          Acquisitions 2007   Acquisitions 2008   Organic Growth


                                                                    Growth by Acquisition Organic Growth

                              M&A GROWTH                                              ORGANIC GROWTH

                         Odonto Empresa: 220k                               Organic growth accelerating retail
                            OralTech: 30k                                             sales channel
                             Fleming: 35k
                           Prevdonto: 130k




8
Assistance Services segment

    Net Revenue (in R$MM)                             Loss Ratio - Assistance (%)

                                                                                     53,5%
                                                              52,1%

                                                                                                 50,4%
                                                                          49,7%
                                      62,4                        50,4%

                                                                          47,1%
                   58,8
                                                                                         45,9%
                3Q07A               3Q08A
                      Net Revenue                             1st Qtr     2nd Qtr    3rd Qtr     4th Qtr


                                                                              2007       2008



                           REVENUE                       LOSS RATIO CURVE
             In 3Q08 the Net Revenues for the            Part of this growth refers to the
             Assistance Segment reached R$ 62,4          increase in the frequency of
             million, which represents a 6,2 %           utilization that the company
             growth compared to 3Q07. The                experienced.
             growth in net revenue occurred
             essentially due to the increase in the      Additionally, in 2008, USS offered
             number of covered items, mainly in          assistances of greater
             personal assistance product, which          complexity, which consequently
             has a lower average ticket than USS         have a higher average cost
             average.


9
Assistance Services segment

     General and Administrative Expenses (in R$MM)              EBITDA (in R$MM)


                        33.0%




                                              25.4%                                  1,6%
                      19,4

                                                                          9,3                    9,4
                                            15,9


                    3Q07A                3Q08A
                                                                      3Q07A                 3Q08A
                  General and Administrative Expenses


                                                       SG&A and EBITDA
                                  Economies of scale and synergies sustaining EBITDA expansion




10
Asset Light Operation
              Capex (R$ MM)                                               YTD/08
              Software                                                      2,9
              IT Equipments                                                2,0
              Buildings                                                     0,0
              Furniture &
              Equipment                                                    0,0
              Other                                                         1,6
              Total                                                        7,3




              Capex vs EBITDA (in R$MM)


                                                              14%
                                    11%           9%
                         8%

                                                                                   EBITDA
                                                             51,1                  CAPEX
                                                55,0
                                   37,6                                            %
                      30,2

                             2,5          4,0          5,1          7,3


                         2005       2006         2007        YTD/08




11
Investors Relations

 Phone: +55 11 4208-8069
E-mail: ri@tempopar.com.br
  www.tempopar.com.br/ri

More Related Content

What's hot

Profarma 4 q11
Profarma 4 q11Profarma 4 q11
Profarma 4 q11
Profarma
 
2012년 hci 실적_발표자료_eng
2012년 hci 실적_발표자료_eng2012년 hci 실적_발표자료_eng
2012년 hci 실적_발표자료_eng
Hyundai Finance
 
ApresentaçãO ConferêNcia Ubs
ApresentaçãO ConferêNcia UbsApresentaçãO ConferêNcia Ubs
ApresentaçãO ConferêNcia Ubs
TIM RI
 
Generali Group 2010 Results
Generali Group 2010 ResultsGenerali Group 2010 Results
Generali Group 2010 Results
Generali
 
Profarma 4 q12
Profarma 4 q12Profarma 4 q12
Profarma 4 q12
Profarma
 
11/13/2007 - 3Q07 Earnings Call Presentation
11/13/2007  	-   	3Q07 Earnings Call Presentation11/13/2007  	-   	3Q07 Earnings Call Presentation
11/13/2007 - 3Q07 Earnings Call Presentation
AES Tietê
 
wyeth UBS Global Life Sciences Conference
wyeth UBS Global Life Sciences Conferencewyeth UBS Global Life Sciences Conference
wyeth UBS Global Life Sciences Conference
finance12
 
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...
finance34
 
dover JPMorgan_060308
dover JPMorgan_060308dover JPMorgan_060308
dover JPMorgan_060308
finance30
 
terex KeyBanc060508
terex KeyBanc060508terex KeyBanc060508
terex KeyBanc060508
finance42
 
Carlisle q12011earningscallpresentation
Carlisle q12011earningscallpresentationCarlisle q12011earningscallpresentation
Carlisle q12011earningscallpresentation
carlisle_com
 

What's hot (16)

Profarma 4 q11
Profarma 4 q11Profarma 4 q11
Profarma 4 q11
 
2012년 hci 실적_발표자료_eng
2012년 hci 실적_발표자료_eng2012년 hci 실적_발표자료_eng
2012년 hci 실적_발표자료_eng
 
ApresentaçãO ConferêNcia Ubs
ApresentaçãO ConferêNcia UbsApresentaçãO ConferêNcia Ubs
ApresentaçãO ConferêNcia Ubs
 
Generali Group 2010 Results
Generali Group 2010 ResultsGenerali Group 2010 Results
Generali Group 2010 Results
 
Profarma 4 q12
Profarma 4 q12Profarma 4 q12
Profarma 4 q12
 
11/13/2007 - 3Q07 Earnings Call Presentation
11/13/2007  	-   	3Q07 Earnings Call Presentation11/13/2007  	-   	3Q07 Earnings Call Presentation
11/13/2007 - 3Q07 Earnings Call Presentation
 
wyeth UBS Global Life Sciences Conference
wyeth UBS Global Life Sciences Conferencewyeth UBS Global Life Sciences Conference
wyeth UBS Global Life Sciences Conference
 
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...
quest diagnostics 864527C3-2EA7-48BF-B6D1-814381520482_2008_Year_End_Presenta...
 
Apre 2 t04
Apre 2 t04Apre 2 t04
Apre 2 t04
 
dover JPMorgan_060308
dover JPMorgan_060308dover JPMorgan_060308
dover JPMorgan_060308
 
Sri Lanka Stock Market Quarterly earnings update sep 2011
Sri Lanka Stock Market Quarterly earnings update sep 2011Sri Lanka Stock Market Quarterly earnings update sep 2011
Sri Lanka Stock Market Quarterly earnings update sep 2011
 
terex KeyBanc060508
terex KeyBanc060508terex KeyBanc060508
terex KeyBanc060508
 
Carlisle q12011earningscallpresentation
Carlisle q12011earningscallpresentationCarlisle q12011earningscallpresentation
Carlisle q12011earningscallpresentation
 
Apresentação 1T09 ENG
Apresentação 1T09 ENGApresentação 1T09 ENG
Apresentação 1T09 ENG
 
Presentation 2Q12
Presentation 2Q12Presentation 2Q12
Presentation 2Q12
 
VIVO - Apresentation of 1st Quarter 2008 Results
VIVO - Apresentation of 1st Quarter 2008 ResultsVIVO - Apresentation of 1st Quarter 2008 Results
VIVO - Apresentation of 1st Quarter 2008 Results
 

Viewers also liked

Earnings%20 Release%201 Q09%20 %20 Presentation
Earnings%20 Release%201 Q09%20 %20 PresentationEarnings%20 Release%201 Q09%20 %20 Presentation
Earnings%20 Release%201 Q09%20 %20 Presentation
Tempo Participações
 
Family-Tree-Structure
Family-Tree-StructureFamily-Tree-Structure
Family-Tree-Structure
xthel fader
 
2008 Treasurer's Report to the Iowa Annual Conference
2008 Treasurer's Report to the Iowa Annual Conference2008 Treasurer's Report to the Iowa Annual Conference
2008 Treasurer's Report to the Iowa Annual Conference
rminshall
 
Hanshin Project
Hanshin ProjectHanshin Project
Hanshin Project
LCEyogurt
 
Tempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 Eng
Tempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 EngTempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 Eng
Tempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 Eng
Tempo Participações
 
Blagounettes
BlagounettesBlagounettes
Blagounettes
Toorop
 
Hanshin Project
Hanshin ProjectHanshin Project
Hanshin Project
LCEyogurt
 
1Q08 Results Conference Call Presentation
1Q08 Results Conference Call Presentation1Q08 Results Conference Call Presentation
1Q08 Results Conference Call Presentation
Tempo Participações
 
Effect Of Coupon On Deals On Dairy Product Sales
Effect Of Coupon On Deals On Dairy Product SalesEffect Of Coupon On Deals On Dairy Product Sales
Effect Of Coupon On Deals On Dairy Product Sales
Mohsin Akbar
 
R21 europacup
R21 europacupR21 europacup
R21 europacup
Toorop
 

Viewers also liked (20)

Earnings%20 Release%201 Q09%20 %20 Presentation
Earnings%20 Release%201 Q09%20 %20 PresentationEarnings%20 Release%201 Q09%20 %20 Presentation
Earnings%20 Release%201 Q09%20 %20 Presentation
 
2010 국제앰네스티 연례보고서
2010 국제앰네스티 연례보고서2010 국제앰네스티 연례보고서
2010 국제앰네스티 연례보고서
 
Teqcorner Presentation 2009
Teqcorner Presentation 2009Teqcorner Presentation 2009
Teqcorner Presentation 2009
 
chemical bonds
chemical bondschemical bonds
chemical bonds
 
Family-Tree-Structure
Family-Tree-StructureFamily-Tree-Structure
Family-Tree-Structure
 
Cowl
CowlCowl
Cowl
 
2008 Treasurer's Report to the Iowa Annual Conference
2008 Treasurer's Report to the Iowa Annual Conference2008 Treasurer's Report to the Iowa Annual Conference
2008 Treasurer's Report to the Iowa Annual Conference
 
Towards Next Generation Urls
Towards Next Generation UrlsTowards Next Generation Urls
Towards Next Generation Urls
 
Hanshin Project
Hanshin ProjectHanshin Project
Hanshin Project
 
Tempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 Eng
Tempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 EngTempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 Eng
Tempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 Eng
 
Malica
MalicaMalica
Malica
 
Blagounettes
BlagounettesBlagounettes
Blagounettes
 
Juangenovs 150227053136-conversion-gate01
Juangenovs 150227053136-conversion-gate01Juangenovs 150227053136-conversion-gate01
Juangenovs 150227053136-conversion-gate01
 
Hanshin Project
Hanshin ProjectHanshin Project
Hanshin Project
 
1Q08 Results Conference Call Presentation
1Q08 Results Conference Call Presentation1Q08 Results Conference Call Presentation
1Q08 Results Conference Call Presentation
 
Contamination
ContaminationContamination
Contamination
 
Effect Of Coupon On Deals On Dairy Product Sales
Effect Of Coupon On Deals On Dairy Product SalesEffect Of Coupon On Deals On Dairy Product Sales
Effect Of Coupon On Deals On Dairy Product Sales
 
Family Tree Structure
Family Tree StructureFamily Tree Structure
Family Tree Structure
 
R21 europacup
R21 europacupR21 europacup
R21 europacup
 
Presentation
PresentationPresentation
Presentation
 

Similar to 3Q08 Earnings Release Presentation

2Q08Results Conference Call Presentation
2Q08Results Conference Call Presentation2Q08Results Conference Call Presentation
2Q08Results Conference Call Presentation
Tempo Participações
 
2Q08Results Conference Call Presentation
2Q08Results Conference Call Presentation2Q08Results Conference Call Presentation
2Q08Results Conference Call Presentation
Tempo Participações
 
Earnings Release 4Q08 Presentation
Earnings Release 4Q08 PresentationEarnings Release 4Q08 Presentation
Earnings Release 4Q08 Presentation
Profarma
 
Conference Call Presentation 4Q09
Conference Call Presentation 4Q09Conference Call Presentation 4Q09
Conference Call Presentation 4Q09
Tempo
 
Earnings Release 4 Q07
Earnings Release 4 Q07Earnings Release 4 Q07
Earnings Release 4 Q07
Profarma
 
Earnings Release 4Q07 Presentation
Earnings Release 4Q07 PresentationEarnings Release 4Q07 Presentation
Earnings Release 4Q07 Presentation
Profarma
 
Earnings Release 3 Q08
Earnings Release 3 Q08Earnings Release 3 Q08
Earnings Release 3 Q08
Profarma
 
Earnings Release 3Q08 Presentation
Earnings Release 3Q08 PresentationEarnings Release 3Q08 Presentation
Earnings Release 3Q08 Presentation
Profarma
 
Earnings Release 1Q09 Presentation
Earnings Release 1Q09 PresentationEarnings Release 1Q09 Presentation
Earnings Release 1Q09 Presentation
Profarma
 
Earnings Release 1 Q09
Earnings Release 1 Q09Earnings Release 1 Q09
Earnings Release 1 Q09
Profarma
 
2008 - Third Quarter Results Us Gaap
2008 - Third Quarter Results Us Gaap2008 - Third Quarter Results Us Gaap
2008 - Third Quarter Results Us Gaap
Embraer RI
 
Profarma Apresentacao 3 Q08 20081105 Eng
Profarma Apresentacao 3 Q08 20081105 EngProfarma Apresentacao 3 Q08 20081105 Eng
Profarma Apresentacao 3 Q08 20081105 Eng
profarma1
 
Profarma Apr2 T08 20080729 Eng
Profarma Apr2 T08 20080729 EngProfarma Apr2 T08 20080729 Eng
Profarma Apr2 T08 20080729 Eng
profarma1
 
Earnings Release 1Q08 Presentation
Earnings Release 1Q08 PresentationEarnings Release 1Q08 Presentation
Earnings Release 1Q08 Presentation
Profarma
 
Earnings Release 1Q08 Presentation
Earnings Release 1Q08 PresentationEarnings Release 1Q08 Presentation
Earnings Release 1Q08 Presentation
Profarma
 
Walgreen Co.Third Quarter 2008 Earnings Conference
Walgreen Co.Third Quarter 2008 Earnings ConferenceWalgreen Co.Third Quarter 2008 Earnings Conference
Walgreen Co.Third Quarter 2008 Earnings Conference
finance4
 
ApresentaçãO Bradesco Evento De Telecom
ApresentaçãO Bradesco Evento De TelecomApresentaçãO Bradesco Evento De Telecom
ApresentaçãO Bradesco Evento De Telecom
TIM RI
 
ApresentaçãO Bradesco Evento De Telecom
ApresentaçãO Bradesco Evento De TelecomApresentaçãO Bradesco Evento De Telecom
ApresentaçãO Bradesco Evento De Telecom
TIM RI
 
Earnings Release 2Q08 Presentation
Earnings Release 2Q08 PresentationEarnings Release 2Q08 Presentation
Earnings Release 2Q08 Presentation
Profarma
 

Similar to 3Q08 Earnings Release Presentation (20)

3Q08 Earnings Release Presentation
3Q08 Earnings Release Presentation3Q08 Earnings Release Presentation
3Q08 Earnings Release Presentation
 
2Q08Results Conference Call Presentation
2Q08Results Conference Call Presentation2Q08Results Conference Call Presentation
2Q08Results Conference Call Presentation
 
2Q08Results Conference Call Presentation
2Q08Results Conference Call Presentation2Q08Results Conference Call Presentation
2Q08Results Conference Call Presentation
 
Earnings Release 4Q08 Presentation
Earnings Release 4Q08 PresentationEarnings Release 4Q08 Presentation
Earnings Release 4Q08 Presentation
 
Conference Call Presentation 4Q09
Conference Call Presentation 4Q09Conference Call Presentation 4Q09
Conference Call Presentation 4Q09
 
Earnings Release 4 Q07
Earnings Release 4 Q07Earnings Release 4 Q07
Earnings Release 4 Q07
 
Earnings Release 4Q07 Presentation
Earnings Release 4Q07 PresentationEarnings Release 4Q07 Presentation
Earnings Release 4Q07 Presentation
 
Earnings Release 3 Q08
Earnings Release 3 Q08Earnings Release 3 Q08
Earnings Release 3 Q08
 
Earnings Release 3Q08 Presentation
Earnings Release 3Q08 PresentationEarnings Release 3Q08 Presentation
Earnings Release 3Q08 Presentation
 
Earnings Release 1Q09 Presentation
Earnings Release 1Q09 PresentationEarnings Release 1Q09 Presentation
Earnings Release 1Q09 Presentation
 
Earnings Release 1 Q09
Earnings Release 1 Q09Earnings Release 1 Q09
Earnings Release 1 Q09
 
2008 - Third Quarter Results Us Gaap
2008 - Third Quarter Results Us Gaap2008 - Third Quarter Results Us Gaap
2008 - Third Quarter Results Us Gaap
 
Profarma Apresentacao 3 Q08 20081105 Eng
Profarma Apresentacao 3 Q08 20081105 EngProfarma Apresentacao 3 Q08 20081105 Eng
Profarma Apresentacao 3 Q08 20081105 Eng
 
Profarma Apr2 T08 20080729 Eng
Profarma Apr2 T08 20080729 EngProfarma Apr2 T08 20080729 Eng
Profarma Apr2 T08 20080729 Eng
 
Earnings Release 1Q08 Presentation
Earnings Release 1Q08 PresentationEarnings Release 1Q08 Presentation
Earnings Release 1Q08 Presentation
 
Earnings Release 1Q08 Presentation
Earnings Release 1Q08 PresentationEarnings Release 1Q08 Presentation
Earnings Release 1Q08 Presentation
 
Walgreen Co.Third Quarter 2008 Earnings Conference
Walgreen Co.Third Quarter 2008 Earnings ConferenceWalgreen Co.Third Quarter 2008 Earnings Conference
Walgreen Co.Third Quarter 2008 Earnings Conference
 
ApresentaçãO Bradesco Evento De Telecom
ApresentaçãO Bradesco Evento De TelecomApresentaçãO Bradesco Evento De Telecom
ApresentaçãO Bradesco Evento De Telecom
 
ApresentaçãO Bradesco Evento De Telecom
ApresentaçãO Bradesco Evento De TelecomApresentaçãO Bradesco Evento De Telecom
ApresentaçãO Bradesco Evento De Telecom
 
Earnings Release 2Q08 Presentation
Earnings Release 2Q08 PresentationEarnings Release 2Q08 Presentation
Earnings Release 2Q08 Presentation
 

More from Tempo Participações

Earnings%20 Release%20 %20 Port%20 %201 T09%20 %20 Apresenta%E7%E3o
Earnings%20 Release%20 %20 Port%20 %201 T09%20 %20 Apresenta%E7%E3oEarnings%20 Release%20 %20 Port%20 %201 T09%20 %20 Apresenta%E7%E3o
Earnings%20 Release%20 %20 Port%20 %201 T09%20 %20 Apresenta%E7%E3o
Tempo Participações
 
Tempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 Port
Tempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 PortTempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 Port
Tempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 Port
Tempo Participações
 
Earnings Release 4Q08 - Presentation
Earnings Release 4Q08 - PresentationEarnings Release 4Q08 - Presentation
Earnings Release 4Q08 - Presentation
Tempo Participações
 
4QO7 Results Conference Call Presentation
4QO7 Results Conference Call Presentation4QO7 Results Conference Call Presentation
4QO7 Results Conference Call Presentation
Tempo Participações
 
Apresentação da Teleconferência de Resultados do 4T07
Apresentação da Teleconferência de Resultados do 4T07Apresentação da Teleconferência de Resultados do 4T07
Apresentação da Teleconferência de Resultados do 4T07
Tempo Participações
 
Apresentação da Teleconferência de Resultados do 2T08
Apresentação da Teleconferência de Resultados do 2T08Apresentação da Teleconferência de Resultados do 2T08
Apresentação da Teleconferência de Resultados do 2T08
Tempo Participações
 
Apresentação da Teleconferência de Resultados do 1 T08
Apresentação da Teleconferência de Resultados do 1 T08Apresentação da Teleconferência de Resultados do 1 T08
Apresentação da Teleconferência de Resultados do 1 T08
Tempo Participações
 
4QO7 Results Conference Call Presentation
4QO7 Results Conference Call Presentation4QO7 Results Conference Call Presentation
4QO7 Results Conference Call Presentation
Tempo Participações
 
Earnings Release 4Q08 - Presentation
Earnings Release 4Q08 - PresentationEarnings Release 4Q08 - Presentation
Earnings Release 4Q08 - Presentation
Tempo Participações
 
4QO7 Results Conference Call Presentation
4QO7 Results Conference Call Presentation4QO7 Results Conference Call Presentation
4QO7 Results Conference Call Presentation
Tempo Participações
 
Release 4T08 - Divulgação de Resultados
Release 4T08 - Divulgação de ResultadosRelease 4T08 - Divulgação de Resultados
Release 4T08 - Divulgação de Resultados
Tempo Participações
 
Gravação da Teleconferência - Resultados 4T08
Gravação da Teleconferência - Resultados 4T08Gravação da Teleconferência - Resultados 4T08
Gravação da Teleconferência - Resultados 4T08
Tempo Participações
 
Apresentação da Teleconferência de Resultados do 4T07
Apresentação da Teleconferência de Resultados do 4T07Apresentação da Teleconferência de Resultados do 4T07
Apresentação da Teleconferência de Resultados do 4T07
Tempo Participações
 
Apresentação da Teleconferência de Resultados do 2T08
Apresentação da Teleconferência de Resultados do 2T08Apresentação da Teleconferência de Resultados do 2T08
Apresentação da Teleconferência de Resultados do 2T08
Tempo Participações
 
Apresentação da Teleconferência de Resultados do 1T08
Apresentação da Teleconferência de Resultados do 1T08Apresentação da Teleconferência de Resultados do 1T08
Apresentação da Teleconferência de Resultados do 1T08
Tempo Participações
 

More from Tempo Participações (19)

Earnings%20 Release%20 %20 Port%20 %201 T09%20 %20 Apresenta%E7%E3o
Earnings%20 Release%20 %20 Port%20 %201 T09%20 %20 Apresenta%E7%E3oEarnings%20 Release%20 %20 Port%20 %201 T09%20 %20 Apresenta%E7%E3o
Earnings%20 Release%20 %20 Port%20 %201 T09%20 %20 Apresenta%E7%E3o
 
Tempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 Port
Tempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 PortTempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 Port
Tempo%20 Participa%E7%F5es%20 %204 T08%20 Apresenta%E7%E3o%20 %20 Port
 
Apresentação dos Resultados 4T08
Apresentação dos Resultados 4T08Apresentação dos Resultados 4T08
Apresentação dos Resultados 4T08
 
Earnings Release 4Q08 - Presentation
Earnings Release 4Q08 - PresentationEarnings Release 4Q08 - Presentation
Earnings Release 4Q08 - Presentation
 
4QO7 Results Conference Call Presentation
4QO7 Results Conference Call Presentation4QO7 Results Conference Call Presentation
4QO7 Results Conference Call Presentation
 
Apresentação - Release 3T08
Apresentação - Release 3T08Apresentação - Release 3T08
Apresentação - Release 3T08
 
Apresentação da Teleconferência de Resultados do 4T07
Apresentação da Teleconferência de Resultados do 4T07Apresentação da Teleconferência de Resultados do 4T07
Apresentação da Teleconferência de Resultados do 4T07
 
Apresentação da Teleconferência de Resultados do 2T08
Apresentação da Teleconferência de Resultados do 2T08Apresentação da Teleconferência de Resultados do 2T08
Apresentação da Teleconferência de Resultados do 2T08
 
Apresentação da Teleconferência de Resultados do 1 T08
Apresentação da Teleconferência de Resultados do 1 T08Apresentação da Teleconferência de Resultados do 1 T08
Apresentação da Teleconferência de Resultados do 1 T08
 
4QO7 Results Conference Call Presentation
4QO7 Results Conference Call Presentation4QO7 Results Conference Call Presentation
4QO7 Results Conference Call Presentation
 
Earnings Release 4Q08
Earnings Release 4Q08Earnings Release 4Q08
Earnings Release 4Q08
 
Earnings Release 4Q08 - Presentation
Earnings Release 4Q08 - PresentationEarnings Release 4Q08 - Presentation
Earnings Release 4Q08 - Presentation
 
4QO7 Results Conference Call Presentation
4QO7 Results Conference Call Presentation4QO7 Results Conference Call Presentation
4QO7 Results Conference Call Presentation
 
Resultados do 3T08
Resultados do 3T08Resultados do 3T08
Resultados do 3T08
 
Release 4T08 - Divulgação de Resultados
Release 4T08 - Divulgação de ResultadosRelease 4T08 - Divulgação de Resultados
Release 4T08 - Divulgação de Resultados
 
Gravação da Teleconferência - Resultados 4T08
Gravação da Teleconferência - Resultados 4T08Gravação da Teleconferência - Resultados 4T08
Gravação da Teleconferência - Resultados 4T08
 
Apresentação da Teleconferência de Resultados do 4T07
Apresentação da Teleconferência de Resultados do 4T07Apresentação da Teleconferência de Resultados do 4T07
Apresentação da Teleconferência de Resultados do 4T07
 
Apresentação da Teleconferência de Resultados do 2T08
Apresentação da Teleconferência de Resultados do 2T08Apresentação da Teleconferência de Resultados do 2T08
Apresentação da Teleconferência de Resultados do 2T08
 
Apresentação da Teleconferência de Resultados do 1T08
Apresentação da Teleconferência de Resultados do 1T08Apresentação da Teleconferência de Resultados do 1T08
Apresentação da Teleconferência de Resultados do 1T08
 

Recently uploaded

FULL ENJOY Call Girls In Mahipalpur Delhi Contact Us 8377877756
FULL ENJOY Call Girls In Mahipalpur Delhi Contact Us 8377877756FULL ENJOY Call Girls In Mahipalpur Delhi Contact Us 8377877756
FULL ENJOY Call Girls In Mahipalpur Delhi Contact Us 8377877756
dollysharma2066
 
Call Girls Electronic City Just Call 👗 7737669865 👗 Top Class Call Girl Servi...
Call Girls Electronic City Just Call 👗 7737669865 👗 Top Class Call Girl Servi...Call Girls Electronic City Just Call 👗 7737669865 👗 Top Class Call Girl Servi...
Call Girls Electronic City Just Call 👗 7737669865 👗 Top Class Call Girl Servi...
amitlee9823
 
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabiunwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
Abortion pills in Kuwait Cytotec pills in Kuwait
 
Call Girls In Noida 959961⊹3876 Independent Escort Service Noida
Call Girls In Noida 959961⊹3876 Independent Escort Service NoidaCall Girls In Noida 959961⊹3876 Independent Escort Service Noida
Call Girls In Noida 959961⊹3876 Independent Escort Service Noida
dlhescort
 
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
daisycvs
 
Nelamangala Call Girls: 🍓 7737669865 🍓 High Profile Model Escorts | Bangalore...
Nelamangala Call Girls: 🍓 7737669865 🍓 High Profile Model Escorts | Bangalore...Nelamangala Call Girls: 🍓 7737669865 🍓 High Profile Model Escorts | Bangalore...
Nelamangala Call Girls: 🍓 7737669865 🍓 High Profile Model Escorts | Bangalore...
amitlee9823
 
Call Now ☎️🔝 9332606886🔝 Call Girls ❤ Service In Bhilwara Female Escorts Serv...
Call Now ☎️🔝 9332606886🔝 Call Girls ❤ Service In Bhilwara Female Escorts Serv...Call Now ☎️🔝 9332606886🔝 Call Girls ❤ Service In Bhilwara Female Escorts Serv...
Call Now ☎️🔝 9332606886🔝 Call Girls ❤ Service In Bhilwara Female Escorts Serv...
Anamikakaur10
 

Recently uploaded (20)

Whitefield CALL GIRL IN 98274*61493 ❤CALL GIRLS IN ESCORT SERVICE❤CALL GIRL
Whitefield CALL GIRL IN 98274*61493 ❤CALL GIRLS IN ESCORT SERVICE❤CALL GIRLWhitefield CALL GIRL IN 98274*61493 ❤CALL GIRLS IN ESCORT SERVICE❤CALL GIRL
Whitefield CALL GIRL IN 98274*61493 ❤CALL GIRLS IN ESCORT SERVICE❤CALL GIRL
 
Business Model Canvas (BMC)- A new venture concept
Business Model Canvas (BMC)-  A new venture conceptBusiness Model Canvas (BMC)-  A new venture concept
Business Model Canvas (BMC)- A new venture concept
 
FULL ENJOY Call Girls In Mahipalpur Delhi Contact Us 8377877756
FULL ENJOY Call Girls In Mahipalpur Delhi Contact Us 8377877756FULL ENJOY Call Girls In Mahipalpur Delhi Contact Us 8377877756
FULL ENJOY Call Girls In Mahipalpur Delhi Contact Us 8377877756
 
Cheap Rate Call Girls In Noida Sector 62 Metro 959961乂3876
Cheap Rate Call Girls In Noida Sector 62 Metro 959961乂3876Cheap Rate Call Girls In Noida Sector 62 Metro 959961乂3876
Cheap Rate Call Girls In Noida Sector 62 Metro 959961乂3876
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investors
 
Call Girls Electronic City Just Call 👗 7737669865 👗 Top Class Call Girl Servi...
Call Girls Electronic City Just Call 👗 7737669865 👗 Top Class Call Girl Servi...Call Girls Electronic City Just Call 👗 7737669865 👗 Top Class Call Girl Servi...
Call Girls Electronic City Just Call 👗 7737669865 👗 Top Class Call Girl Servi...
 
Falcon Invoice Discounting platform in india
Falcon Invoice Discounting platform in indiaFalcon Invoice Discounting platform in india
Falcon Invoice Discounting platform in india
 
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabiunwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
 
Call Girls Service In Old Town Dubai ((0551707352)) Old Town Dubai Call Girl ...
Call Girls Service In Old Town Dubai ((0551707352)) Old Town Dubai Call Girl ...Call Girls Service In Old Town Dubai ((0551707352)) Old Town Dubai Call Girl ...
Call Girls Service In Old Town Dubai ((0551707352)) Old Town Dubai Call Girl ...
 
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdfDr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
 
Falcon Invoice Discounting: Empowering Your Business Growth
Falcon Invoice Discounting: Empowering Your Business GrowthFalcon Invoice Discounting: Empowering Your Business Growth
Falcon Invoice Discounting: Empowering Your Business Growth
 
Call Girls In Noida 959961⊹3876 Independent Escort Service Noida
Call Girls In Noida 959961⊹3876 Independent Escort Service NoidaCall Girls In Noida 959961⊹3876 Independent Escort Service Noida
Call Girls In Noida 959961⊹3876 Independent Escort Service Noida
 
Malegaon Call Girls Service ☎ ️82500–77686 ☎️ Enjoy 24/7 Escort Service
Malegaon Call Girls Service ☎ ️82500–77686 ☎️ Enjoy 24/7 Escort ServiceMalegaon Call Girls Service ☎ ️82500–77686 ☎️ Enjoy 24/7 Escort Service
Malegaon Call Girls Service ☎ ️82500–77686 ☎️ Enjoy 24/7 Escort Service
 
Uneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration PresentationUneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration Presentation
 
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
 
Nelamangala Call Girls: 🍓 7737669865 🍓 High Profile Model Escorts | Bangalore...
Nelamangala Call Girls: 🍓 7737669865 🍓 High Profile Model Escorts | Bangalore...Nelamangala Call Girls: 🍓 7737669865 🍓 High Profile Model Escorts | Bangalore...
Nelamangala Call Girls: 🍓 7737669865 🍓 High Profile Model Escorts | Bangalore...
 
The Path to Product Excellence: Avoiding Common Pitfalls and Enhancing Commun...
The Path to Product Excellence: Avoiding Common Pitfalls and Enhancing Commun...The Path to Product Excellence: Avoiding Common Pitfalls and Enhancing Commun...
The Path to Product Excellence: Avoiding Common Pitfalls and Enhancing Commun...
 
👉Chandigarh Call Girls 👉9878799926👉Just Call👉Chandigarh Call Girl In Chandiga...
👉Chandigarh Call Girls 👉9878799926👉Just Call👉Chandigarh Call Girl In Chandiga...👉Chandigarh Call Girls 👉9878799926👉Just Call👉Chandigarh Call Girl In Chandiga...
👉Chandigarh Call Girls 👉9878799926👉Just Call👉Chandigarh Call Girl In Chandiga...
 
Call Now ☎️🔝 9332606886🔝 Call Girls ❤ Service In Bhilwara Female Escorts Serv...
Call Now ☎️🔝 9332606886🔝 Call Girls ❤ Service In Bhilwara Female Escorts Serv...Call Now ☎️🔝 9332606886🔝 Call Girls ❤ Service In Bhilwara Female Escorts Serv...
Call Now ☎️🔝 9332606886🔝 Call Girls ❤ Service In Bhilwara Female Escorts Serv...
 
PHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation FinalPHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation Final
 

3Q08 Earnings Release Presentation

  • 2. Business segments Healthcare Administration Services Dental HMO Assistance Services Ranking: #1 Ranking: #4 Ranking: #1 Number of lives: 1.38 million Number of lives: 751 thousand Number of items: 21.3 million No underwriting risk. Fee business Underwriting of frequency risk only. Underwriting of frequency risk Shared structure Network management – Contact Center – Claims processing 2
  • 3. Recent events ACQUISITION DENTAL – Today, November 13, 2008, Tempo announces an acquisition of 55% stake of Presdental Assistência Odontológica Empresarial S.A. (Presdental), a dental plan company offering services to approximately 35 thousand beneficiaries. The acquisition of 6% is still subject to ANS approval (Brazilian Health Regulatory Agency). ACQUISITION HEALTH – On 08/31/2008, Tempo acquired 100% stake of Multicare Consultoria e Administração de Recursos em Saúde (“Multicare”), with a total of approximately 15 thousand lives. The acquisition of 51% is still subject to ANS approval. Multicare provides health services to self-insured companies. STOCK BUYBACK PROGRAM - Tempo announced that its Board of Directors approved on 11/13/08 a Buyback program of common shares. The maximum number of common shares on this Buyback program is of 8,276,702 and will last for 365 days. 3
  • 5. Tempo - Consolidaded Net Revenue - Tempo (R$MM) EBITDA - Tempo ($RMM) Margem EBITDA - Tempo ($RMM) 189,8 9,9% 18,8 142,4 9,3% 13,2 3Q07A 3Q08A 3T07A EBITDA 3T08A 3T07A 3T08A Net Revenue Margem EBITDA NET REVENUES EBITDA EBITDA Margin Net Revenue grew 33.3% in 3Q08 Economies of scale and synergies versus the same period of the continue to boost margins M & A Transactions during 08 and previous year, reaching a total of R$ synergies 189.8 million. 5
  • 6. Health segment Net Revenue (in R$MM) General and Administrative Expenses (in R$MM) Adjusted EBITDA (in R$MM) 14.9% 16.1% 5.4% 3.6% 112,0 78,2 16,7 12,6 6,1 2,8 3Q07A 3Q08A 3Q07A 3Q08A Net Revenue General and Administrative Expenses 3Q07A 3Q08A REVENUES SG&A EBITDA Revenue growth driven by lives Health segment accumulated a EBITDA powered by growth and increase and Home Care acquisition. total of R$ 16.7 MM in SG&A M&A Growth for 3Q08 came to R$ expenses during the 3Q08, which 33.8MM was R$ 4,1 million above 3Q07. Despite the increase in expenses, Health segment growth in this period generated economies of scale, improving the business margin 6
  • 7. Dental segment: 2008 pro forma results Net Revenue (in R$MM) Cost of Rendered Services (in R$MM) EBITDA (in R$MM) 21,8% 50.2% 43.1% 20,4% 24,0 10,8 5,2 2,7 5,4 1,1 3Q07A 3Q08A 3Q07A 3Q08A 3Q07A 3Q08A REVENUES LOSS RATIO EBITDA Strong top line growth powered by Significant improvement in loss ratio Continues EBITDA margin expansion M&A and solid organic growth All figures in this slide take into consideration the acquisitions made in 2007 and consolidated into the Company's financials starting January 1st, 2008 even though they were waiting for approval by ANS. 7
  • 8. Strong combination between organic and M&A growth Growth Breakdown - Dental Segment Growth by Acquisition Organic Growth 26% 29% 45% 93% 23% Acquisitions 2007 Acquisitions 2008 Organic Growth Growth by Acquisition Organic Growth M&A GROWTH ORGANIC GROWTH Odonto Empresa: 220k Organic growth accelerating retail OralTech: 30k sales channel Fleming: 35k Prevdonto: 130k 8
  • 9. Assistance Services segment Net Revenue (in R$MM) Loss Ratio - Assistance (%) 53,5% 52,1% 50,4% 49,7% 62,4 50,4% 47,1% 58,8 45,9% 3Q07A 3Q08A Net Revenue 1st Qtr 2nd Qtr 3rd Qtr 4th Qtr 2007 2008 REVENUE LOSS RATIO CURVE In 3Q08 the Net Revenues for the Part of this growth refers to the Assistance Segment reached R$ 62,4 increase in the frequency of million, which represents a 6,2 % utilization that the company growth compared to 3Q07. The experienced. growth in net revenue occurred essentially due to the increase in the Additionally, in 2008, USS offered number of covered items, mainly in assistances of greater personal assistance product, which complexity, which consequently has a lower average ticket than USS have a higher average cost average. 9
  • 10. Assistance Services segment General and Administrative Expenses (in R$MM) EBITDA (in R$MM) 33.0% 25.4% 1,6% 19,4 9,3 9,4 15,9 3Q07A 3Q08A 3Q07A 3Q08A General and Administrative Expenses SG&A and EBITDA Economies of scale and synergies sustaining EBITDA expansion 10
  • 11. Asset Light Operation Capex (R$ MM) YTD/08 Software 2,9 IT Equipments 2,0 Buildings 0,0 Furniture & Equipment 0,0 Other 1,6 Total 7,3 Capex vs EBITDA (in R$MM) 14% 11% 9% 8% EBITDA 51,1 CAPEX 55,0 37,6 % 30,2 2,5 4,0 5,1 7,3 2005 2006 2007 YTD/08 11
  • 12. Investors Relations Phone: +55 11 4208-8069 E-mail: ri@tempopar.com.br www.tempopar.com.br/ri